Relation of serum uric acid to cardiovascular disease

Audrey H Wu1, James D Gladden2, Mustafa Ahmed3

  • 1Cardiovascular Center, University of Michigan Health Systems, Ann Arbor, MI, USA.

Insights

Serum uric acid is complexly linked to cardiovascular disease, potentially acting as a risk marker or causative agent. Elevated levels correlate with adverse outcomes and increased risk for various heart conditions.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Clinical Biochemistry

Background:

  • The relationship between serum uric acid and cardiovascular disease (CVD) is intricate and not fully understood.
  • Serum uric acid levels are influenced by biological factors and are associated with conditions like hypertension, dyslipidemia, obesity, and impaired glucose metabolism, which contribute to CVD.
  • Existing literature suggests a link between elevated serum uric acid and adverse health outcomes, including mortality in the general population.

Purpose of the Study:

  • To review and synthesize recent literature on the association between serum uric acid levels and cardiovascular disease.
  • To explore the potential roles of serum uric acid as a risk marker, causative agent, or both in CVD development and progression.

Main Methods:

  • Systematic review of published literature.
  • Analysis of studies investigating the correlation between serum uric acid and various cardiovascular conditions and outcomes.

Main Results:

  • Serum uric acid is associated with an increased risk of developing coronary heart disease, heart failure, and atrial fibrillation.
  • In patients with established systolic heart failure, higher serum uric acid levels correlate with greater disease severity and increased mortality risk.
  • Serum uric acid levels are linked to hypertension, dyslipidemia, obesity, and impaired glucose metabolism, all contributing factors to cardiovascular disease.

Conclusions:

  • The association between serum uric acid and cardiovascular disease is multifaceted, with evidence suggesting it may serve as both a risk indicator and a potential contributor.
  • Further research is needed to determine if therapeutic interventions targeting serum uric acid levels can positively impact clinical cardiovascular outcomes.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
770
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
858
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
849
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
625